On October 24, 2018, the President signed a new bill aimed at combating the opioid addiction epidemic that is sweeping the nation - the SUPPORT Act of 2018.  The full Congressional summary of the the SUPPORT Act is available here. The SUPPORT Act will have a far-reaching impact on all healthcare providers and establish many additional mandatory compliance requirements.   Of particular interest to pharmacy providers is the new provision that would lead to the establishment of a national database aimed at tracking "suspicious orders" for opioids. 

In our upcoming client alerts, we will break down many provisions of the law and analyze their impact on various types of healthcare practices.

For guidance from expert legal counsel on compliance obligations of healthcare providers under the ever-changing legal and regulatory regime, do not hesitate to contact our knowledgeable and experienced attorneys at 212-668-0200 or by email at info@mdrxlaw.com.